P

Inventor

KUMAR V SATISH

US31 patents
⚠️ This page may combine multiple inventors who share the name “KUMAR V SATISH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BIOCRYST PHARM INC

27 patents
US10329260B2Jun 25, 2019

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC26 citations98
US10125102B2Nov 13, 2018

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC24 citations98
US7560434B2Jul 14, 2009

AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

BIOCRYST PHARM INC92 citations97
US7514410B2Apr 7, 2009

Hepatitis C therapies

BIOCRYST PHARM INC80 citations97
US7994139B2Aug 9, 2011

Antiviral therapeutic agents

BIOCRYST PHARM INC81 citations95
US10689346B2Jun 23, 2020

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC10 citations92
US10633345B2Apr 28, 2020

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC10 citations92
US11708333B2Jul 25, 2023

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC2 citations84
US11708332B2Jul 25, 2023

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC2 citations84
US11230530B2Jan 25, 2022

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC5 citations84
US11203574B2Dec 21, 2021

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC5 citations84
US11192861B2Dec 7, 2021

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC5 citations84
US11370774B2Jun 28, 2022

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

BIOCRYST PHARM INC4 citations83
US11021458B2Jun 1, 2021

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

BIOCRYST PHARM INC5 citations83
US12162838B2Dec 10, 2024

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC0 citations73
US12116346B2Oct 15, 2024

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC0 citations73
US11685721B2Jun 27, 2023

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC2 citations73
US10562850B2Feb 18, 2020

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC2 citations73
US12043610B2Jul 23, 2024

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

BIOCRYST PHARM INC1 citations72
US11866418B2Jan 9, 2024

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

BIOCRYST PHARM INC2 citations72
US11708347B2Jul 25, 2023

Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

BIOCRYST PHARM INC3 citations72
US11661426B2May 30, 2023

Imidazole-containing inhibitors of ALK2 kinase

BIOCRYST PHARM INC2 citations72
US12054492B2Aug 6, 2024

Imidazole-containing inhibitors of ALK2 kinase

BIOCRYST PHARM INC0 citations62
US11807605B2Nov 7, 2023

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC0 citations62
US11618731B2Apr 4, 2023

Prodrugs of kallikrein inhibitors

BIOCRYST PHARM INC0 citations62
US11066360B2Jul 20, 2021

Human plasma kallikrein inhibitors

BIOCRYST PHARM INC1 citations62
US10759759B2Sep 1, 2020

Prodrugs of kallikrein inhibitors

BIOCRYST PHARM INC1 citations62

BABU YARLAGADDA S

3 patents

BIOCRYST PHARMACETICALS INC

1 patent